Assessment of Imaging Modalities Against Liver Biopsy in Nonalcoholic Fatty Liver Disease: The Amsterdam NAFLD‐NASH Cohort-Reference-Cited by-同舟云学术

Assessment of Imaging Modalities Against Liver Biopsy in Nonalcoholic Fatty Liver Disease: The Amsterdam NAFLD‐NASH Cohort

Published:2021-05-15 Issue:6 Volume:54 Page:1937-1949
ISSN:1053-1807
Container-title:Journal of Magnetic Resonance Imaging
language:en
Short-container-title:J Magn Reson Imaging

Author:

Troelstra Marian A.¹^ORCID,Witjes Julia J.²^ORCID,Dijk Anne‐Marieke²,Mak Anne L.²,Gurney‐Champion Oliver¹,Runge Jurgen H.¹^ORCID,Zwirs Diona²,Stols‐Gonçalves Daniela²,Zwinderman Aelko H.³,Wolde Marije⁴,Monajemi Houshang⁵,Ramsoekh Sandjai⁶,Sinkus Ralph⁷⁸,Delden Otto M.¹,Beuers Ulrich H.⁶,Verheij Joanne⁹,Nieuwdorp Max²,Nederveen Aart J.¹,Holleboom Adriaan G.²

Affiliation:

1. Department of Radiology and Nuclear Medicine Amsterdam University Medical Centres Amsterdam The Netherlands

2. Department of Internal and Vascular Medicine Amsterdam University Medical Centres Amsterdam The Netherlands

3. Department of Clinical Epidemiology, Biostatistics and Bioinformatics Amsterdam University Medical Centres Amsterdam The Netherlands

4. Department of Internal Medicine Flevoziekenhuis Almere The Netherlands

5. Department of Internal Medicine Rijnstate Ziekenhuis Arnhem The Netherlands

6. Department of Gastroenterology and Hepatology Amsterdam University Medical Centres Amsterdam The Netherlands

7. Inserm U1148, LVTS University Paris Diderot, University Paris 13 Paris France

8. School of Biomedical Engineering and Imaging Sciences King's College London London UK

9. Department of Pathology Amsterdam University Medical Centres Amsterdam The Netherlands

Publisher

Wiley

Subject

Radiology Nuclear Medicine and imaging

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmri.27703

Reference45 articles.

1. Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

2. Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum

3. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis

4. Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

5. Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) in a middle-aged population with overweight and normal liver enzymes, and diagnostic accuracy of noninvasive proxies;Medicine;2024-01-05

2. Intrapancreatic fat deposition is unrelated to liver steatosis in metabolic dysfunction-associated steatotic liver disease;JHEP Reports;2024-01

3. Repeatability and reproducibility comparisons of liver IVIM imaging with free‐breathing or respiratory‐triggered sequences;NMR in Biomedicine;2023-12-19

4. NASH drug treatment development: challenges and lessons;The Lancet Gastroenterology & Hepatology;2023-10

5. Ectopic lipid deposition in muscle and liver, quantified by proton magnetic resonance spectroscopy;Obesity;2023-09-05